MAPK3 and head and neck squamous cell carcinoma: We demonstrated that EGFR has a dual capacity to either induce proliferation or EMT in HNSCC cells, a phenomenon that was dependent upon the strength of activation of the downstream effector kinase Erk1/2 [143].